Biochemistry, Genetics and Molecular Biology
Anabolism
8%
Biogenesis
9%
Blood Plasma
8%
Cancer Cell
16%
Cancer Growth Factor
8%
Carcinogenesis
12%
Case-Control Study
34%
Cohort Study
8%
Comorbidity
8%
DNA Content
8%
DNA Hypomethylation
8%
DNA Methylation
8%
Expression Quantitative Trait Loci
9%
Gene Dosage
11%
Gene Polymorphism
17%
Genetic Association
17%
Genetic Divergence
69%
Genetic Variation
48%
Genetics
24%
Genome-Wide Association Study
20%
Genomics
16%
Genotyping
13%
Germ Cell
8%
Germline
8%
Immune Checkpoints
17%
Immune Response
18%
Leukocyte
17%
Liver Function
8%
Matrilysin
8%
Mesenchymal-Epithelial Transition
8%
MicroRNA
44%
Mitochondrial DNA
26%
Nanog
8%
Octamer Transcription Factor 4
8%
Overall Survival
17%
Passive Smoking
8%
Peripheral Blood Lymphocyte
8%
Pharmacogenetics
8%
Regulator of G Protein Signalling
8%
Response Factor
8%
Serum Total Protein
12%
Signaling Protein
8%
Single Nucleotide Polymorphism
13%
Single-Nucleotide Polymorphism
100%
Smoking
10%
Stem Cell
12%
T Cell
26%
Telomere
17%
Telomere Length
20%
Wnt Signaling Pathway
8%
Keyphrases
Biochemical Recurrence
16%
Bladder Cancer
21%
Cancer Patients
10%
Clinical Outcomes
26%
Confidence Interval
22%
DNA Damage
11%
DNA Hypomethylation
8%
Double-strand Breaks
8%
Early-stage Lung Cancer
17%
Field Synopsis
8%
Genetic Variants
45%
Genetic Variation
17%
H2AX
26%
Hazard Ratio
17%
High Risk
9%
Inflammation Pathway
10%
Ionizing Radiation
14%
Localized Prostate Cancer
17%
Lung Cancer Risk
17%
Mexican Americans
8%
MicroRNA
16%
Mitochondrial DNA Copy number
17%
Mitochondrial DNA Variation
8%
Non-muscle Invasive Bladder Cancer (NMIBC)
17%
Odds Ratio
10%
Peripheral Blood
9%
Peripheral Blood Leukocytes
19%
Peripheral Blood Lymphocytes
12%
Physical Component Summary
14%
Physical Quality of Life
8%
Predictors of Progression
8%
Prognostic Value
11%
Quality of Life
17%
Radiation Effects
11%
Recurrence Prediction
17%
Recurrence Risk
9%
Relative Telomere Length
9%
Renal Cell Carcinoma
10%
Risk Factors
10%
Serum Proteins
8%
Single nucleotide Polymorphism
45%
Soluble Immune Checkpoint-related Protein
8%
Survival Prediction
9%
Systemic Inflammatory Response
8%
Telomere
17%
Telomere Length
16%
Transforming Growth Factor-β
8%
Transurethral Resection
9%
Tumorigenesis
15%
γH2AX
8%
Pharmacology, Toxicology and Pharmaceutical Science
Adenoma
6%
Biochemical Recurrence
8%
Biological Marker
21%
Bladder Cancer
47%
C Peptide
7%
Cancer Growth
10%
Cancer Recurrence
8%
Carcinogenesis
14%
Case-Control Study
11%
Circulating microRNA
9%
Colorectal Adenoma
9%
Colorectal Carcinoma
17%
Diseases
6%
Gastric Inhibitory Polypeptide
7%
Glutathione
8%
Hypoxia Inducible Factor 1
5%
Inflammation
21%
Interleukin 6
8%
Ionizing Radiation
12%
Liver Cell Carcinoma
8%
Lung Adenocarcinoma
8%
Lung Cancer
8%
Malignant Neoplasm
33%
Matrilysin
8%
Matrix Metalloproteinase
7%
microRNA
44%
microRNA 155
8%
microRNA 210
8%
Mitochondrial DNA
8%
Neoplasm
16%
Non Muscle Invasive Bladder Cancer
42%
Non Small Cell Lung Cancer
17%
Octamer Transcription Factor 4
8%
Overall Survival
5%
Pancreas Adenocarcinoma
8%
Polyp
5%
Prostate Cancer
8%
Recurrent Disease
46%
Renal Cell Carcinoma
17%
Tumor Necrosis Factor
8%
Vitamin D
5%
Vorinostat
5%
